Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Ruben, J.M."'
Autor:
Essen, M.F. van, Schlagwein, N., Gijlswijk-Janssen, D.J. van, Ruben, J.M., Kooten, C. van, COMBAT Consortium
Publikováno v:
Immunobiology, 227(4). ELSEVIER GMBH
The complement system does not only play an important role in the defence against microorganism and pathogens, but also contributes to the regulation of innate and adaptive immunity. Especially activation fragments C3a and C5a and complement activati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f041d1c39ca8cd3876ff015c079d1e28
https://hdl.handle.net/1887/3563169
https://hdl.handle.net/1887/3563169
Autor:
Essen, M.F. van, Schlagwein, N., Hoven, E.M.P. van den, Gijlswijk-Janssen, D.J. van, Lubbers, R., Bos, R.M. van den, Born, J. van den, Ruben, J.M., Trouw, L.A., Kooten, C. van, COMBAT Consortium
Publikováno v:
European Journal of Immunology, 52(4), 597-608. Wiley
Properdin, the only known positive regulator of the complement system, stabilizes the C3 convertase, thereby increasing its half-life. In contrast to most other complement factors, properdin is mainly produced extrahepatically by myeloid cells. Recen
Autor:
Essen, M.F. van, Ruben, J.M., Vries, A.P.J. de, Kooten, C. van, Berger, S., Born, J. van den, Gros, P., Heuvel, L. van den, Kar, N. van de, Seelen, M., Vries, A. de, COMBAT Consortium
Publikováno v:
Nephrology Dialysis Transplantation, 34(5), 742-750
As part of the innate immune system, the complement system is an important mechanism in our first line of defence, but it can also contribute to the onset of various diseases. In renal diseases, the dysregulation of the complement system is often cau
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92c2f2592698fd32a3935f6aa0f5194b
https://doi.org/10.1093/ndt/gfy233
https://doi.org/10.1093/ndt/gfy233
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Essen, M.F. van, Schlagwein, N., Gijlswijk-Janssen, D.J. van, Anholts, J.D.H., Eikmans, M., Ruben, J.M., Kooten, C. van, COMBAT Consortium
Publikováno v:
Journal of Immunological Methods, 479. ELSEVIER
Gene silencing using small interfering ribonucleic acids (siRNA) is a powerful method to interfere with gene expression, allowing for the functional exploration of specific genes. siRNA interference can be applied in both cell lines, as well as in pr
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ruben, J.M.
Publikováno v:
Ruben, J M 2015, ' Tumor-derived apoptotic bleb vaccines for the treatment of Acute Myeloid Leukemia ', PhD, Vrije Universiteit Amsterdam .
Ruben, J M 2015, ' Tumor-derived apoptotic bleb vaccines for the treatment of Acute Myeloid Leukemia ', Doctor of Philosophy, VU University .
Ruben, J M 2015, ' Tumor-derived apoptotic bleb vaccines for the treatment of Acute Myeloid Leukemia ', Doctor of Philosophy, VU University .
promotiedatum: 17-11-2015 � prom-id: 12868
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0e9cfb4b9e874504c571e7b5d039f768
Autor:
Ruben, J.M., van den Ancker, W., Westers, T.M., Ossenkoppele, G.J., de Gruijl, T.D., van de Loosdrecht, A.A.
Publikováno v:
Nederlands Tijdschrift voor Hematologie, 11(3), 91-99
Ruben, J M, van den Ancker, W, Westers, T M, Ossenkoppele, G J, de Gruijl, T D & van de Loosdrecht, A A 2014, ' Actieve immuuntherapie bij acute myeloïde leukemie ', Nederlands Tijdschrift voor Hematologie, vol. 11, no. 3, pp. 91-99 . < http://www.ariez.nl/DownloadFile.lynkx?guid=5a090d4f-f761-43c8-b649-9ef5045fd838 >
Ruben, J M, van den Ancker, W, Westers, T M, Ossenkoppele, G J, de Gruijl, T D & van de Loosdrecht, A A 2014, ' Actieve immuuntherapie bij acute myeloïde leukemie ', Nederlands Tijdschrift voor Hematologie, vol. 11, no. 3, pp. 91-99 . < http://www.ariez.nl/DownloadFile.lynkx?guid=5a090d4f-f761-43c8-b649-9ef5045fd838 >
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7c58d88a4b92b83fbf2c5f207ee9686d
https://research.vumc.nl/en/publications/43ca0f02-d7db-4912-aa48-c354616b6f7b
https://research.vumc.nl/en/publications/43ca0f02-d7db-4912-aa48-c354616b6f7b
Autor:
Schneiders, F.L., Prodohl, J., Ruben, J.M., O'Toole, T.G., Scheper, R.J., Bonneville, M., Scotet, E., Verheul, H.M.W., de Gruijl, T.D., van der Vliet, H.J.
Publikováno v:
Cancer Immunology Research, 2(8), 732-740. American Association for Cancer Research Inc.
Schneiders, F L, Prodohl, J, Ruben, J M, O'Toole, T G, Scheper, R J, Bonneville, M, Scotet, E, Verheul, H M W, de Gruijl, T D & van der Vliet, H J 2014, ' CD1d-Restricted Antigen Presentation by V gamma 9V delta 2-T Cells Requires Trogocytosis ', Cancer Immunology Research, vol. 2, no. 8, pp. 732-740 . https://doi.org/10.1158/2326-6066.CIR-13-0167
Schneiders, F L, Prodohl, J, Ruben, J M, O'Toole, T G, Scheper, R J, Bonneville, M, Scotet, E, Verheul, H M W, de Gruijl, T D & van der Vliet, H J 2014, ' CD1d-Restricted Antigen Presentation by V gamma 9V delta 2-T Cells Requires Trogocytosis ', Cancer Immunology Research, vol. 2, no. 8, pp. 732-740 . https://doi.org/10.1158/2326-6066.CIR-13-0167
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::29cf92a447a8574102781926f0f8c446
https://research.vumc.nl/en/publications/46334931-56d6-4ed7-81b0-42f919c3dcc6
https://research.vumc.nl/en/publications/46334931-56d6-4ed7-81b0-42f919c3dcc6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.